Biography
Jessica Kokosinski serves as Vice President at G&L Scientific, leading the firm’s specialized focus on Advanced Therapy Medicinal Products (ATMPs) and Orphan Drug designations.
With a career spanning two decades in regulatory strategy, Jessica is an expert in the expedited pathways of the FDA and EMA.
She is currently spearheading G&L’s task force on the 2026 EU AI Act and its implications for clinical data integrity.
Jessica is a long-standing member of RAPS and is frequently cited as an expert on the regulatory hurdles of Gene and Cell Therapies.
